glp-1 drugs insurance coverage of Obesity Therapies in State-Regulated Markets Does health insurance cover GLP-1

Suter, Megan E

Figure 26: Photograph of Professor Jens Holst with Dr Karen Thorne, a member of his laboratory, carrying out an experiment with a perfused pig pancreas in the 1990s, credit: Holst

The most common risks of oral GLP-1s like Rybelsus, Wegovy pill, and Foundayo include : Acute pancreatitis Diabetic retinopathy complications (diabetes-related vision changes) Hypoglycemia (low blood sugar), especially when used with insulin Kidney or gallbladder issues Severe gastrointestinal reactions Allergic reactions Pulmonary aspiration during general anesthesia or deep sedation All three GLP-1s also carry a black box warning for thyroid tumors based on animal studies

These record sales have occurred despite limited insurance coverage in the U.S., with neither Wegovy nor Zepbound broadly covered by employer plans or Medicare

too often makes getting a prescription into a frustrating, exhausting obstacle course